您的位置: 首页 > 农业专利 > 详情页

新穎之人類T細胞群
专利权人:
KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
发明人:
NAKAMURA, SHUJI,中村修治,MOTODA, RYUICHI,元田龙一,元田龍一,KIBATA, MASAYOSHI,木畑正义,木畑正義,ORITA, KUNZO,折田薰三,YAMASAKI, FUMIYUKI,山崎史行
申请号:
TW096108806
公开号:
TWI410495B
申请日:
2007.03.14
申请国别(地区):
TW
年份:
2013
代理人:
摘要:
The present invention has objects to provide a novel human T-cell population having both cytotoxic and immunosuppressive activities, and to a method for preparing the same. The above objects are attained by providing a human T-cell population which is obtainable by coculturing mononuclear cells, collected from human blood, with stroma cells and which has the following features: (1) being positive for CD3, CD25, CD28 and T-cell antigen receptor ±²; (2) essentially consisting of three groups of a CD4 positive and CD8 positive (CD4 + CD8 + ) T-cell group, a CD4 positive and CD8 dimly positive (CD4 + CD8 dim ) T-cell group, and a CD4 negative and CD8 positive (CD4 - CD8 + ) T-cell group; (3) exerting a cytotoxic activity against the cocultured stroma cells; and (4) exerting an immunosuppressive activity against activated T cells.本發明係提供一種具有細胞毒性及免疫抑制性2者兼具之新穎之人類T細胞群,並以提供其取得方法為課題,其可藉將由人血採取之單核球細胞與基質細胞一起培養而獲得,且具有下述之特徵:(1)CD3、CD25、CD28及T細胞抗原受體α β為陽性、(2)本質上由CD4陽性CD8陽性T細胞、CD4陽性CD8弱陽性T細胞及CD4陰性CD8陽性T細胞之三群所成、(3)相對於共同培養之基質細胞,可發揮造成細胞毒性,以及(4)對於活化之T細胞,發揮免疫抑制之活性。
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充